169 related articles for article (PubMed ID: 37787998)
1. Potential of Fecal Microbiota Transplantation to Prevent Acute GVHD: Analysis from a Phase II Trial.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Clin Cancer Res; 2023 Dec; 29(23):4920-4929. PubMed ID: 37787998
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
[TBL] [Abstract][Full Text] [Related]
4. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
[TBL] [Abstract][Full Text] [Related]
5. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.
Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
J Clin Oncol; 2023 Dec; 41(34):5306-5319. PubMed ID: 37235836
[TBL] [Abstract][Full Text] [Related]
6. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
[No Abstract] [Full Text] [Related]
8. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.
Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L
Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
Front Immunol; 2021; 12():678476. PubMed ID: 34220825
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
[TBL] [Abstract][Full Text] [Related]
13. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety].
Goloshchapov OV; Chukhlovin AB; Bakin EA; Stanevich OV; Klementeva RV; Shcherbakov AA; Shvetsov AN; Suvorova MA; Bondarenko SN; Kucher MA; Kulagin AD; Zubarovskaya LS; Moiseev IS
Ter Arkh; 2020 Sep; 92(7):43-54. PubMed ID: 33346444
[TBL] [Abstract][Full Text] [Related]
14. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
15. Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics.
Podlesny D; Durdevic M; Paramsothy S; Kaakoush NO; Högenauer C; Gorkiewicz G; Walter J; Fricke WF
Cell Rep Med; 2022 Aug; 3(8):100711. PubMed ID: 35931074
[TBL] [Abstract][Full Text] [Related]
16. Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
van Lier YF; Rolling T; Armijo GK; Zhai B; Haverkate NJE; Meijer E; Nur E; Blom B; Peled JU; van den Brink MRM; Hohl TM; Hazenberg MD; Markey KA
Transplant Cell Ther; 2023 Jan; 29(1):63.e1-63.e5. PubMed ID: 36280104
[TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
18. Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study).
Dougé A; Ravinet A; Corriger A; Cabrespine A; Wasiak M; Pereira B; Sokol H; Nguyen S; Bay JO
BMJ Open; 2023 May; 13(5):e068480. PubMed ID: 37130682
[TBL] [Abstract][Full Text] [Related]
19. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
Kakihana K
Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
[TBL] [Abstract][Full Text] [Related]
20. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]